McLaren M - Search Results

1

The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome.

Lau CS, Khan F, McLaren M, Bancroft A, Walker M, Belch JJ. Lau CS, et al. Among authors: mclaren m. Rheumatol Int. 1991;11(4-5):163-8. doi: 10.1007/BF00332555. Rheumatol Int. 1991. PMID: 1838424 Clinical Trial.

2

Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.

Lau CS, McLaren M, Belch JJ. Lau CS, et al. Among authors: mclaren m. Br J Rheumatol. 1991 Dec;30(6):433-6. doi: 10.1093/rheumatology/30.6.433. Br J Rheumatol. 1991. PMID: 1747698

3

The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis--a preliminary study.

Lau CS, McLaren M, Saniabadi A, Scott N, Belch JJ. Lau CS, et al. Among authors: mclaren m. Clin Exp Rheumatol. 1991 May-Jun;9(3):271-3. Clin Exp Rheumatol. 1991. PMID: 1879086 Clinical Trial.

4

Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.

Lau CS, McLaren M, Saniabadi A, Belch JJ. Lau CS, et al. Among authors: mclaren m. Scand J Rheumatol. 1993;22(3):97-101. doi: 10.3109/03009749309099251. Scand J Rheumatol. 1993. PMID: 8316776

5

Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.

Belch JJ, McLaren M, Lau CS, Mackay IR, Bancroft A, McEwen J, Thompson JM. Belch JJ, et al. Among authors: mclaren m. Br J Clin Pharmacol. 1993 Jun;35(6):643-7. doi: 10.1111/j.1365-2125.1993.tb04195.x. Br J Clin Pharmacol. 1993. PMID: 8329292 Free PMC article. Clinical Trial.

6

Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.

Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJ. Khan F, et al. Among authors: mclaren m. Arthritis Rheum. 1997 Feb;40(2):352-7. doi: 10.1002/art.1780400220. Arthritis Rheum. 1997. PMID: 9041947 Clinical Trial.

7

Activated factor XII in rheumatoid arthritis.

McLaren M, Alkaabi J, Connacher M, Belch JJ, Valenete E. McLaren M, et al. Rheumatol Int. 2002 Sep;22(5):182-4. doi: 10.1007/s00296-002-0219-6. Epub 2002 Aug 9. Rheumatol Int. 2002. PMID: 12215862

8

The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial.

Muir AH, Robb R, McLaren M, Daly F, Belch JJ. Muir AH, et al. Among authors: mclaren m. Vasc Med. 2002;7(4):265-7. doi: 10.1191/1358863x02vm455oa. Vasc Med. 2002. PMID: 12710841 Clinical Trial.

9

Dark chocolate inhibits platelet aggregation in healthy volunteers.

Innes AJ, Kennedy G, McLaren M, Bancroft AJ, Belch JJ. Innes AJ, et al. Among authors: mclaren m. Platelets. 2003 Aug;14(5):325-7. doi: 10.1080/0953710031000123681. Platelets. 2003. PMID: 12944249 Free article. Clinical Trial.

10

Is chronic fatigue syndrome associated with platelet activation?

Kennedy G, Norris G, Spence V, McLaren M, Belch JJ. Kennedy G, et al. Among authors: mclaren m. Blood Coagul Fibrinolysis. 2006 Mar;17(2):89-92. doi: 10.1097/01.mbc.0000214705.80997.73. Blood Coagul Fibrinolysis. 2006. PMID: 16479189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters